NASDAQ : MOBI
Mobia Medical, Inc. — Financial statements
Healthcare · Medical Devices · United States
Last price 11.27 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 375.19M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Mobia Medical, Inc. (MOBI) reported revenue of 45.28M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Revenue | 45.28M | 32.04M | 15.64M |
| Cost of Revenue | 8.27M | 6.07M | 3.19M |
| Gross Profit | 37.02M | 25.98M | 12.45M |
| Selling, General & Admin | 89.77M | 65.83M | 32.44M |
| Research & Development | 7.71M | 6.52M | 4.24M |
| Operating Expenses | 97.48M | 72.34M | 36.69M |
| Operating Income | -60.47M | -46.37M | -24.24M |
| Interest Expense | -1.10M | -967.37K | -969.92K |
| Other Non Operating Income (Expenses) | -2.57M | 842.53K | 617.11K |
| Pretax Income | -64.13M | -46.49M | -24.59M |
| Income Tax Expense | 4.45K | 5.45K | 13.91K |
| Net Income | -64.14M | -46.50M | -24.60M |
| Net Income to Common | -64.14M | -46.50M | -24.60M |
| Shares Outstanding (Basic) | 6.86M | 2.25M | 2.00M |
| Shares Outstanding (Diluted) | 6.86M | 2.25M | 2.00M |
| EPS (Basic) | -9.34 | -20.64 | -12.29 |
| EPS (Diluted) | -9.35 | -20.64 | -12.29 |
| Free Cash Flow | -60.29M | -46.06M | -24.36M |
| Free Cash Flow Per Share | -8.79 | -20.45 | -12.17 |
| Gross Margin | 81.75% | 81.07% | 79.59% |
| Operating Margin | -133.53% | -144.71% | -154.92% |
| Profit Margin | -141.63% | -145.12% | -157.26% |
| Free Cash Flow Margin | -133.14% | -143.75% | -155.69% |
| EBITDA | -60.19M | -46.22M | -24.12M |
| EBITDA Margin | -132.91% | -144.24% | -154.18% |
| D&A For EBITDA | 279.66K | 151.66K | 116.01K |
| EBIT | -60.47M | -46.37M | -24.24M |
| EBIT Margin | -133.53% | -144.71% | -154.92% |
| Advertising Expenses | 3.44M | 1.32M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Cash & Equivalents | 177.09M | 33.59M | 14.62M |
| Cash & Short-Term Investments | 177.09M | 33.59M | 14.62M |
| Receivables | 5.66M | 4.44M | 2.83M |
| Inventory | 6.95M | 5.46M | 3.43M |
| Other Current Assets | 2.45M | 2.88M | 299.02K |
| Total Current Assets | 192.15M | 46.36M | 21.17M |
| Property, Plant & Equipment | 2.99M | 1.74M | 894.96K |
| Other Long-Term Assets | 143.00K | 53.88K | 21.33K |
| Total Assets | 195.28M | 48.15M | 22.09M |
| Accounts Payable | 2.36M | 2.22M | 1.14M |
| Accrued Expenses | 6.99M | 5.37M | 2.93M |
| Current Portion of Leases | 358.00K | 357.52K | 23.65K |
| Other Current Liabilities | 4.76M | 2.26M | 499.53K |
| Total Current Liabilities | 14.47M | 10.21M | 4.60M |
| Long-Term Debt | 7.28M | 7.13M | 7.09M |
| Long-Term Leases | 790.00K | 947.89K | 603.05K |
| Other Long-Term Liabilities | 134.00K | 865.39K | 1.01M |
| Total Liabilities | 22.68M | 19.15M | 13.30M |
| Common Stock | 333.00K | 30.79K | 27.05K |
| Additional Paid-In Capital | 368.85M | 6.98M | 5.23M |
| Retained Earnings | -196.57M | -157.79M | -111.29M |
| Total Common Equity | 172.61M | -150.77M | -106.04M |
| Shareholders' Equity | 172.61M | 29.00M | 8.79M |
| Total Liabilities & Equity | 195.28M | 48.15M | 22.09M |
| Total Debt | 8.43M | 8.44M | 7.72M |
| Net Cash (Debt) | 168.66M | 25.15M | 6.90M |
| Net Cash Per Share | 24.57 | 11.17 | 3.45 |
| Filing Date Shares Outstanding | 33.29M | 3.08M | 2.71M |
| Total Common Shares Outstanding | 33.29M | 3.08M | 2.71M |
| Working Capital | 177.68M | 36.15M | 16.58M |
| Book Value Per Share | 5.19 | -48.97 | -39.19 |
| Tangible Book Value | 172.61M | -150.77M | -106.04M |
| Tangible Book Value Per Share | 5.19 | -48.97 | -39.19 |
| Machinery | 125.23K | 114.07K | |
| Leasehold Improvements | 848.30K | 568.28K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Net Income | -64.14M | -46.50M | -24.60M |
| Depreciation & Amortization | 279.66K | 151.66K | 116.01K |
| Other Amortization | 166.86K | 35.86K | 35.86K |
| Stock-Based Compensation | 2.86M | 1.45M | 758.13K |
| Other Operating Activities | 4.38M | 92.66K | 12.44K |
| Change in Accounts Receivable | -2.79M | -1.61M | -1.39M |
| Change in Inventory | -2.44M | -2.03M | -245.41K |
| Change in Accounts Payable | 1.34M | 1.08M | -108.59K |
| Change in Other Net Operating Assets | 1.98M | 1.63M | 1.11M |
| Operating Cash Flow | -58.37M | -45.69M | -24.32M |
| Capital Expenditures | -1.92M | -364.41K | -40.85K |
| Investing Cash Flow | -1.92M | -364.41K | -40.85K |
| Issuance of Common Stock | 138.57M | 313.70K | 671.63K |
| Other Financing Activities | -1.35K | ||
| Financing Cash Flow | 211.07M | 65.03M | 15.66M |
| Net Cash Flow | 150.78M | 18.97M | -8.70M |
| Free Cash Flow | -60.29M | -46.06M | -24.36M |
| Free Cash Flow Margin | -133.14% | -143.75% | -155.69% |
| Free Cash Flow Per Share | -8.79 | -20.45 | -12.17 |
| Levered Free Cash Flow | -29.25M | ||
| Unlevered Free Cash Flow | -28.69M | ||
| Cash Interest Paid | 931.51K | 931.51K | 969.92K |
| Cash Income Tax Paid | 725.00 | 2.73K | 13.91K |
| Change in Working Capital | -1.91M | -923.68K | -634.72K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | |
|---|---|---|---|
| Market Capitalization | 352.22M | ||
| Enterprise Value | 183.56M | ||
| Debt / Equity Ratio | 0.05 | 0.29 | 0.88 |
| Net Debt / Equity Ratio | -0.98 | -0.87 | -0.79 |
| Net Debt / EBITDA Ratio | 2.80 | 0.54 | 0.29 |
| Net Debt / FCF Ratio | 2.80 | 0.55 | 0.28 |
| Asset Turnover | 0.91 | ||
| Inventory Turnover | 1.36 | ||
| Quick Ratio | 12.63 | 3.73 | 3.79 |
| Current Ratio | 13.28 | 4.54 | 4.61 |
| Return on Equity (ROE) | -246.09% | ||
| Return on Assets (ROA) | -82.52% | ||
| Return on Capital Employed (ROCE) | -33.40% | -122.20% | -138.50% |
| Buyback Yield / Dilution | -12.54% |